iohexol has been researched along with Heart Diseases in 16 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The secondary endpoints are absolute and relative increases in sCr of at least 50%, thrombolysis in myocardial infarction (TIMI) perfusion grade, and major adverse cardiac events at 1, 6, and 12 months." | 2.75 | The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study. ( Angioli, P; Bolognese, L; Carrera, A; Ducci, K; Falsini, G; Grotti, S; Liistro, F; Limbruno, U; Picchi, A; Pierli, C, 2010) |
| "Gadolinium-based contrast agents can be used in diagnostic and interventional angiography, and are safe in recommended doses in patients with impaired renal function, but the image quality is usually unsatisfactory." | 2.72 | Safety of gadodiamide mixed with a small quantity of iohexol in patients with impaired renal function undergoing coronary angiography. ( Barcin, C; Isik, E; Iyisoy, A; Kose, S; Kursaklioglu, H; Tore, HF, 2006) |
| "This rare pulmonary embolism complication can be easily detected on multidetector computed tomography using a wider scan range." | 1.36 | Pulmonary embolism associated with inferior vena cava interruption: multidetector computed tomography findings. ( Chae, EJ; Hyun, DH; Kim, M; Lee, CW; Lee, HJ; Seo, JB; Song, JW, 2010) |
| "The incidence of renal failure (as a percentage of total reports) was approximately 3." | 1.30 | Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. ( Berry, CC; Lasser, EC; Lyon, SG, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yeo, LLL | 1 |
| Holmin, S | 1 |
| Andersson, T | 1 |
| Lundström, E | 1 |
| Gopinathan, A | 1 |
| Lim, EL | 1 |
| Leong, BSH | 1 |
| Kuan, WS | 1 |
| Ting, E | 1 |
| Tan, BYQ | 1 |
| Eide, SE | 1 |
| Tay, ELK | 1 |
| McCullough, PA | 1 |
| Todoran, TM | 1 |
| Brilakis, ES | 1 |
| Ryan, MP | 1 |
| Gunnarsson, C | 1 |
| Masuda, T | 1 |
| Nakaura, T | 1 |
| Funama, Y | 1 |
| Sato, T | 1 |
| Nitta, T | 1 |
| Higaki, T | 1 |
| Baba, Y | 1 |
| Matsumoto, Y | 1 |
| Imada, N | 1 |
| Awai, K | 1 |
| Inokuchi, G | 1 |
| Yajima, D | 1 |
| Hayakawa, M | 1 |
| Motomura, A | 1 |
| Chiba, F | 1 |
| Torimitsu, S | 1 |
| Makino, Y | 1 |
| Iwase, H | 1 |
| Treweeke, AT | 1 |
| Maskrey, BH | 1 |
| Hickson, K | 1 |
| Miller, JH | 1 |
| Leslie, SJ | 1 |
| Megson, IL | 1 |
| Bolognese, L | 1 |
| Falsini, G | 1 |
| Grotti, S | 1 |
| Limbruno, U | 1 |
| Liistro, F | 1 |
| Carrera, A | 1 |
| Angioli, P | 1 |
| Picchi, A | 1 |
| Ducci, K | 1 |
| Pierli, C | 1 |
| Hyun, DH | 1 |
| Seo, JB | 1 |
| Chae, EJ | 1 |
| Lee, CW | 1 |
| Lee, HJ | 1 |
| Kim, M | 1 |
| Song, JW | 1 |
| Tsai, HY | 1 |
| Chen, MC | 1 |
| Tsai, IC | 1 |
| Chen, CC | 1 |
| Artunc, FH | 1 |
| Fischer, IU | 1 |
| Risler, T | 1 |
| Erley, CM | 1 |
| Niboshi, A | 1 |
| Nishida, M | 1 |
| Itoi, T | 1 |
| Shiraishi, I | 1 |
| Hamaoka, K | 1 |
| Barcin, C | 1 |
| Kursaklioglu, H | 1 |
| Iyisoy, A | 1 |
| Kose, S | 1 |
| Tore, HF | 1 |
| Isik, E | 1 |
| Nyman, U | 1 |
| Elmståhl, B | 1 |
| Nilsson, M | 1 |
| Mancini, GB | 1 |
| Atwood, JE | 1 |
| Bhargava, V | 1 |
| Slutsky, RA | 1 |
| Grover, M | 1 |
| Higgins, CB | 1 |
| Hill, JA | 1 |
| Winniford, M | 1 |
| Cohen, MB | 1 |
| Van Fossen, DB | 1 |
| Murphy, MJ | 1 |
| Halpern, EF | 1 |
| Ludbrook, PA | 1 |
| Wexler, L | 1 |
| Rudnick, MR | 1 |
| Goldfarb, S | 1 |
| Lasser, EC | 1 |
| Lyon, SG | 1 |
| Berry, CC | 1 |
| Gare, M | 1 |
| Haviv, YS | 1 |
| Ben-Yehuda, A | 1 |
| Rubinger, D | 1 |
| Bdolah-Abram, T | 1 |
| Fuchs, S | 1 |
| Gat, O | 1 |
| Popovtzer, MM | 1 |
| Gotsman, MS | 1 |
| Mosseri, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Contrast Media and Nephrotoxicity Following Coronary Revascularization by Primary Angioplasty for Acute Myocardial Infarction. The CONTRAST-AMI Study.[NCT00827788] | Phase 4 | 432 participants (Anticipated) | Interventional | 2008-12-31 | Completed | ||
| Department of Geriatrics[NCT02575092] | Phase 2/Phase 3 | 4,000 participants (Actual) | Interventional | 2015-11-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for iohexol and Heart Diseases
| Article | Year |
|---|---|
Iodixanol Has a Favourable Fibrinolytic Profile Compared to Iohexol in Cardiac Patients Undergoing Elective Angiography: A Double-Blind, Randomized, Parallel Group Study.
Topics: Aged; Angiography; Contrast Media; Double-Blind Method; Heart Diseases; Humans; Iohexol; Male; Middl | 2016 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Cor | 2010 |
Safety of gadodiamide mixed with a small quantity of iohexol in patients with impaired renal function undergoing coronary angiography.
Topics: Aged; Azotemia; Comorbidity; Contrast Media; Coronary Angiography; Creatinine; Drug Combinations; Fe | 2006 |
Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study.
Topics: Adult; Aged; Aged, 80 and over; Angiocardiography; Cardiovascular Diseases; Contrast Media; Creatini | 1993 |
The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography.
Topics: Cardiotonic Agents; Contrast Media; Coronary Angiography; Creatinine; Diabetes Complications; Dopami | 1999 |
11 other studies available for iohexol and Heart Diseases
| Article | Year |
|---|---|
Nongated Cardiac Computed Tomographic Angiograms for Detection of Embolic Sources in Acute Ischemic Stroke.
Topics: Aged; Aorta, Thoracic; Aortic Aneurysm; Aortic Dissection; Atrial Appendage; Brain Ischemia; Compute | 2017 |
Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Catheterization; Cerebrovas | 2019 |
Effect of Patient Characteristics on Vessel Enhancement in Pediatric Chest Computed Tomography Angiography.
Topics: Age Factors; Aorta; Body Height; Body Surface Area; Body Weight; Cardiac Output; Computed Tomography | 2019 |
The utility of postmortem computed tomography selective coronary angiography in parallel with autopsy.
Topics: Adult; Aged; Aged, 80 and over; Animals; Autopsy; Cause of Death; Contrast Media; Coronary Angiograp | 2013 |
Pulmonary embolism associated with inferior vena cava interruption: multidetector computed tomography findings.
Topics: Aged; Anticoagulants; Contrast Media; Diagnosis, Differential; Heart Diseases; Heparin; Humans; Iohe | 2010 |
Partial ring artifact on cardiac CT: image presentation and clinical implication.
Topics: Aged; Artifacts; Contrast Media; Equipment Failure; Female; Heart Diseases; Humans; Iohexol; Predict | 2011 |
Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiac Catheterization; Contrast Media; Creatinine; Cys | 2005 |
Renal function and cardiac angiography.
Topics: Adolescent; Cardiac Catheterization; Child; Child, Preschool; Contrast Media; Cyanosis; Heart Diseas | 2006 |
The dogma that gadolinium contrast media are less nephrotoxic than iodine agents for X-ray angiography is a misconception.
Topics: Aged; Azotemia; Comorbidity; Contrast Media; Coronary Angiography; Creatinine; Drug Combinations; Fe | 2007 |
Comparative effects of ionic and nonionic contrast materials on indexes of isovolumic contraction and relaxation in humans.
Topics: Coronary Angiography; Diatrizoate; Diatrizoate Meglumine; Double-Blind Method; Heart Diseases; Hemod | 1984 |
Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Cause of Death; | 1997 |